Who are the 10 key players in the $226B spine biologics market?

The global spine biologics market is projected to grow at a 4.4 percent compound annual growth rate, from $226 billion in 2018 to $280 billion by 2023, according to a Market Data Forecast report.

Here are the top 10 players in the market:

1. Alphatec Holdings

2. DePuy Synthes

3. Exactech

4. Globus Medical

5. Medtronic

6. NuVasive

7. Orthofix

8. RTI Surgical

9. SeaSpine

10. Zimmer Biomet

More articles on biologics:

206 Ortho gets bio-inspired patent: 3 quick notes

Emory Orthopaedics & Spine Center receives $13M to study stem cell osteoarthritis treatments: 4 notes

Bone Biologics raises $5.9M: 3 notes